Calliditas Therapeutics AB (CALT) Stock Price, Quote, News and Overview

What is the stock price of Calliditas Therapeutics AB today?

The current stock price of CALT is 40.0001 USD. The price decreased by -0.4% in the last trading session.

What is the ticker symbol for Calliditas Therapeutics AB stock?

The exchange symbol of Calliditas Therapeutics AB is CALT and it is listed on the Nasdaq exchange.

On which exchange is CALT stock listed?

CALT stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for Calliditas Therapeutics AB stock?

13 analysts have analysed CALT and the average price target is 45.37 USD. This implies a price increase of 13.42% is expected in the next year compared to the current price of 40.0001. Check the Calliditas Therapeutics AB stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is Calliditas Therapeutics AB worth?

Calliditas Therapeutics AB (CALT) has a market capitalization of 1.08B USD. This makes CALT a Small Cap stock.

How many employees does Calliditas Therapeutics AB have?

Calliditas Therapeutics AB (CALT) currently has 219 employees.

What are the support and resistance levels for Calliditas Therapeutics AB (CALT) stock?

Calliditas Therapeutics AB (CALT) has a support level at 39.5 and a resistance level at 40.1. Check the full technical report for a detailed analysis of CALT support and resistance levels.

Is Calliditas Therapeutics AB (CALT) expected to grow?

The Revenue of Calliditas Therapeutics AB (CALT) is expected to grow by 70.05% in the next year. Check the estimates tab for more information on the CALT EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy Calliditas Therapeutics AB (CALT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CALT, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CALT, evaluating the profitability, health, valuation and growth aspects
• Calliditas Therapeutics AB (CALT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Calliditas Therapeutics AB (CALT) Sales and EPS estimates to see what analysts future expectations are.
• Calliditas Therapeutics AB (CALT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Calliditas Therapeutics AB (CALT) Insider and Institutional Ownership to learn about the owners and their transactions.
• Calliditas Therapeutics AB (CALT) Stock Chart to make your own analysis
• Calliditas Therapeutics AB (CALT) Latest news and press-releases to stay up to date.

Does Calliditas Therapeutics AB (CALT) stock pay dividends?

CALT does not pay a dividend.

When does Calliditas Therapeutics AB (CALT) report earnings?

Calliditas Therapeutics AB (CALT) will report earnings on 2024-11-11, before the market open.

What is the Price/Earnings (PE) ratio of Calliditas Therapeutics AB (CALT)?

Calliditas Therapeutics AB (CALT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.76).

ChartMill assigns a fundamental rating of 3 / 10 to CALT. CALT has a bad profitability rating. Also its financial health evaluation is rather negative.

Over the last trailing twelve months CALT reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS decreased by -64.52% compared to the year before.

ChartMill assigns a Buy % Consensus number of 82% to CALT. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of 127% and a revenue growth 70.05% for CALT